1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 RESIDUES A 1 - A 10, A 99 - A 105, B 1 - B 2, AND B 11 - B 12 ARE DISORDERED IN SOLUTION; THEREFORE, COORDINATES DISPLAY LARGE RMSD VALUES FOR THESE ATOMS. Pascal, S.M. Singer, A.U. Gish, G. Yamazaki, T. Shoelson, S.E. Pawson, T. Kay, L.E. Forman-Kay, J.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C9 H12 N O6 P 261.168 n O-PHOSPHOTYROSINE PHOSPHONOTYROSINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Cell(Cambridge,Mass.) CELLB5 0998 0092-8674 77 461 472 10.1016/0092-8674(94)90160-0 8181064 Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. 1994 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 12275.924 PHOSPHOLIPASE C GAMMA-1, C-TERMINAL SH2 DOMAIN 3.1.4.11 1 man polymer 1480.532 PHOSPHOPEPTIDE FROM PDGF 1 man polymer no no GSPGIHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDL ISYYEKHPLYRKMKLRYPINEENSS GSPGIHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDL ISYYEKHPLYRKMKLRYPINEENSS A polypeptide(L) no yes DND(PTR)IIPLPDPK DNDYIIPLPDPK B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n cattle Bos sample 9913 Bos taurus cattle Bos sample 9913 Bos taurus pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1995-01-26 1 1 2008-03-03 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1994-08-19 REL 1 BRUNGER refinement X-PLOR GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A PRO 3 n 3 PRO 3 A GLY 4 n 4 GLY 4 A ILE 5 n 5 ILE 5 A HIS 6 n 6 HIS 6 A GLU 7 n 7 GLU 7 A SER 8 n 8 SER 8 A LYS 9 n 9 LYS 9 A GLU 10 n 10 GLU 10 A TRP 11 n 11 TRP 11 A TYR 12 n 12 TYR 12 A HIS 13 n 13 HIS 13 A ALA 14 n 14 ALA 14 A SER 15 n 15 SER 15 A LEU 16 n 16 LEU 16 A THR 17 n 17 THR 17 A ARG 18 n 18 ARG 18 A ALA 19 n 19 ALA 19 A GLN 20 n 20 GLN 20 A ALA 21 n 21 ALA 21 A GLU 22 n 22 GLU 22 A HIS 23 n 23 HIS 23 A MET 24 n 24 MET 24 A LEU 25 n 25 LEU 25 A MET 26 n 26 MET 26 A ARG 27 n 27 ARG 27 A VAL 28 n 28 VAL 28 A PRO 29 n 29 PRO 29 A ARG 30 n 30 ARG 30 A ASP 31 n 31 ASP 31 A GLY 32 n 32 GLY 32 A ALA 33 n 33 ALA 33 A PHE 34 n 34 PHE 34 A LEU 35 n 35 LEU 35 A VAL 36 n 36 VAL 36 A ARG 37 n 37 ARG 37 A LYS 38 n 38 LYS 38 A ARG 39 n 39 ARG 39 A ASN 40 n 40 ASN 40 A GLU 41 n 41 GLU 41 A PRO 42 n 42 PRO 42 A ASN 43 n 43 ASN 43 A SER 44 n 44 SER 44 A TYR 45 n 45 TYR 45 A ALA 46 n 46 ALA 46 A ILE 47 n 47 ILE 47 A SER 48 n 48 SER 48 A PHE 49 n 49 PHE 49 A ARG 50 n 50 ARG 50 A ALA 51 n 51 ALA 51 A GLU 52 n 52 GLU 52 A GLY 53 n 53 GLY 53 A LYS 54 n 54 LYS 54 A ILE 55 n 55 ILE 55 A LYS 56 n 56 LYS 56 A HIS 57 n 57 HIS 57 A CYS 58 n 58 CYS 58 A ARG 59 n 59 ARG 59 A VAL 60 n 60 VAL 60 A GLN 61 n 61 GLN 61 A GLN 62 n 62 GLN 62 A GLU 63 n 63 GLU 63 A GLY 64 n 64 GLY 64 A GLN 65 n 65 GLN 65 A THR 66 n 66 THR 66 A VAL 67 n 67 VAL 67 A MET 68 n 68 MET 68 A LEU 69 n 69 LEU 69 A GLY 70 n 70 GLY 70 A ASN 71 n 71 ASN 71 A SER 72 n 72 SER 72 A GLU 73 n 73 GLU 73 A PHE 74 n 74 PHE 74 A ASP 75 n 75 ASP 75 A SER 76 n 76 SER 76 A LEU 77 n 77 LEU 77 A VAL 78 n 78 VAL 78 A ASP 79 n 79 ASP 79 A LEU 80 n 80 LEU 80 A ILE 81 n 81 ILE 81 A SER 82 n 82 SER 82 A TYR 83 n 83 TYR 83 A TYR 84 n 84 TYR 84 A GLU 85 n 85 GLU 85 A LYS 86 n 86 LYS 86 A HIS 87 n 87 HIS 87 A PRO 88 n 88 PRO 88 A LEU 89 n 89 LEU 89 A TYR 90 n 90 TYR 90 A ARG 91 n 91 ARG 91 A LYS 92 n 92 LYS 92 A MET 93 n 93 MET 93 A LYS 94 n 94 LYS 94 A LEU 95 n 95 LEU 95 A ARG 96 n 96 ARG 96 A TYR 97 n 97 TYR 97 A PRO 98 n 98 PRO 98 A ILE 99 n 99 ILE 99 A ASN 100 n 100 ASN 100 A GLU 101 n 101 GLU 101 A GLU 102 n 102 GLU 102 A ASN 103 n 103 ASN 103 A SER 104 n 104 SER 104 A SER 105 n 105 SER 105 A ASP 1 n 1 ASP 1 B ASN 2 n 2 ASN 2 B ASP 3 n 3 ASP 3 B PTR 4 n 4 PTR 4 B ILE 5 n 5 ILE 5 B ILE 6 n 6 ILE 6 B PRO 7 n 7 PRO 7 B LEU 8 n 8 LEU 8 B PRO 9 n 9 PRO 9 B ASP 10 n 10 ASP 10 B PRO 11 n 11 PRO 11 B LYS 12 n 12 LYS 12 B author_defined_assembly 2 dimeric B PTR 4 O-PHOSPHOTYROSINE B PTR 4 TYR 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N HIS 13 A N HIS 13 A O VAL 36 A O VAL 36 A N LEU 35 A N LEU 35 A O SER 48 A O SER 48 A N ILE 47 A N ILE 47 A O CYS 58 A O CYS 58 A N GLN 61 A N GLN 61 A O MET 68 A O MET 68 A O VAL 67 A O VAL 67 A N PHE 74 A N PHE 74 1 A ARG 18 0.313 SIDE CHAIN 1 A ARG 27 0.308 SIDE CHAIN 1 A ARG 30 0.167 SIDE CHAIN 1 A ARG 39 0.231 SIDE CHAIN 1 A ARG 50 0.309 SIDE CHAIN 1 A ARG 59 0.279 SIDE CHAIN 1 A ARG 91 0.212 SIDE CHAIN 1 A HIS 6 -178.11 -142.09 1 A GLU 7 49.03 -125.21 1 A SER 8 47.61 -144.79 1 A LYS 9 -171.89 -168.47 1 A GLU 10 49.75 11.93 1 A ARG 30 177.83 164.59 1 A ALA 33 -170.20 121.55 1 A ARG 39 -74.52 -166.10 1 A ASN 40 -92.14 31.64 1 A PRO 42 -77.83 24.43 1 A SER 44 166.75 144.81 1 A GLU 52 61.95 -118.08 1 A THR 66 -152.40 -157.20 1 A TYR 90 -110.25 -163.14 1 A ARG 91 -77.67 25.23 1 A LYS 92 -178.66 -43.22 1 A LEU 95 -99.07 42.90 1 A PRO 98 -77.68 -140.10 1 A GLU 101 171.94 173.71 1 A SER 104 -82.80 -77.70 1 B PTR 4 176.87 137.73 1 B ASP 10 69.12 142.89 model building X-PLOR refinement X-PLOR phasing X-PLOR PHOSPHOLIPASE C GAMMA-1, C-TERMINAL SH2 DOMAIN NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE 1 N N 2 N N A THR 17 A THR 17 HELX_P A VAL 28 A VAL 28 1 A 12 A LEU 77 A LEU 77 HELX_P SL.IRR., BIFURCATED H-BONDS A HIS 87 A HIS 87 1 B 11 covale 1.307 B ASP 3 B C ASP 3 1_555 B PTR 4 B N PTR 4 1_555 covale 1.313 B PTR 4 B C PTR 4 1_555 B ILE 5 B N ILE 5 1_555 PHOSPHORIC DIESTER HYDROLASE PHOSPHORIC DIESTER HYDROLASE PLCG1_BOVIN UNP 1 1 P08487 MAGAASPCANGCGPSAPSDAEVVHLCRSLEVGTVMTLFYSKKSQRPERKTFQVKLETRQITWSRGADKIEGAIDIREIKE IRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTLSLQATSEDEVNMWIRGLTWLMEDTLQAATPLQIERWLRKQ FYSVDRNREDRISAKDLKNMLSQVNYRVPNMRFLRERLTDLEQRTSDITYGQFAQLYRSLMYSAQKTMDLPFLEASALRA GERPELCRVSLPEFQQFLLEYQGELWAVDRLQVQEFMLSFLRDPLREIEEPYFFLDEFVTFLFSKENSIWNSQLDEVCPD TMNNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMGCRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLHTIKEH AFVASEYPVILSIEDHCSIAQQRNMAQYFKKVLGDTLLTKPVDIAADGLPSPNQLKRKILIKHKKLAEGSAYEEVPTSVM YSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSSDQGNEDEEEPKEASGSTELHSNEKWFHGKLGAGRD GRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQ QVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQE GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNPGFYVEANPMPTFKCAVKALF DYKAQREDELTFTKSAIIQNVEKQEGGWWRGDYGGKKQLWFPSNYVEEMVSPAALEPEREHLDENSPLGDLLRGVLDVPA CQIAVRPEGKNNRLFVFSISMASVAHWSLDVAADSQEELQDWVKKIREVAQTADARLTEGKMMERRKKIALELSELVVYC RPVPFDEEKIGTERACYRDMSSFPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDSSNYDPLPMWICGSQLVALNF QTPDKPMQMNQALFLAGGHCGYVLQPSVMRDEAFDPFDKSSLRGLEPCAICIEVLGARHLPKNGRGIVCPFVEIEVAGAE YDSIKQKTEFVVDNGLNPVWPAKPFHFQISNPEFAFLRFVVYEEDMFSDQNFLAQATFPVKGLKTGYRAVPLKNNYSEGL ELASLLVKIDVFPAKQENGDLSPFGGASLRERSCDASGPLFHGRAREGSFEARYQQPFEDFRISQEHLADHFDGRDRRTP RRTRVNGDNRL PGDR_HUMAN UNP 2 1 P09619 MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGT FSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTL HEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGN EVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLG EVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFH EDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNV TYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKP RYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTA RSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNAL PVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSY MDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLY TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLER LLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEG SPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL 663 759 2PLD 6 102 P08487 A 1 6 102 1018 1029 2PLD 1 12 P09619 B 2 1 12 4 3 parallel anti-parallel anti-parallel anti-parallel anti-parallel A TRP 11 A TRP 11 A HIS 13 A HIS 13 A PHE 34 A PHE 34 A LYS 38 A LYS 38 A TYR 45 A TYR 45 A ALA 51 A ALA 51 A LYS 54 A LYS 54 A VAL 60 A VAL 60 A GLN 61 A GLN 61 A GLU 63 A GLU 63 A THR 66 A THR 66 A LEU 69 A LEU 69 A SER 72 A SER 72 A PHE 74 A PHE 74 1 P 1